Embody receives FDA clearance for bioengineered collagen-based implant
Click Here to Manage Email Alerts
Embody Inc. has received FDA 510(k) clearance for its T biointegrative implant for tendon and ligament repair, according to a press release.
Utilizing a proprietary micro-architecture, the T implant is specifically designed for soft tissue injuries, which accounted for 2.4 million surgeries in the US in 2019, according to the release.
“This FDA clearance represents a major milestone in the advancement of Embodys mission to improve outcomes for patients who suffer from tendon and ligament injuries,” Jeff Conroy, CEO of Embody, said in the release. “We believe T represents a significant advancement in collagen science and provides surgeons with a compelling solution with broad clinical utility for tendon repair procedures,” he added.
Read more about
Click Here to Manage Email Alerts